AIM-listed Allergy Therapeutics raises 拢55m & agrees loan facility
Allergy Therapeutics has strengthened its finances after raising 拢55 million from the exercise of 1.38 billion lender warrants, using the proceeds to fully repay its shareholder loan and clear all outstanding debt. The West Sussex-based MedTech, which develops allergy vaccines and immunotherapy treatments, said the move leaves it with a stronger balance sheet and more … Continue reading AIM-listed Allergy Therapeutics raises 拢55m & agrees loan facility
